Evergreen Capital Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
Evergreen Capital Management's IBB Position: Q3 2026 in Review
Evergreen Capital Management reduced its iShares Biotechnology ETF (IBB) stake by 1.2% in Q3 2026, selling an estimated $64K and leaving 27,108 shares worth $5.71M. The position accounts for 0.1% of the portfolio, ranked #184.
Evergreen Capital Management first reported a position in IBB in Q2 2018 and has held it in 21 quarters since. The position peaked at $8.45M in Q1 2023. 995 funds tracked by Wall St. Rank hold IBB as of Q3 2026.
- Evergreen Capital Management held 27,108 shares of iShares Biotechnology ETF worth $5.71M as of Q3 2026.
- Evergreen Capital Management sold 319 iShares Biotechnology ETF shares in Q3 2026, an estimated $64K.
- iShares Biotechnology ETF made up 0.1% of Evergreen Capital Management's portfolio in Q3 2026, its #184 holding.
- Evergreen Capital Management first reported a position in iShares Biotechnology ETF in Q2 2018 and has held it in 21 quarters since.
- Evergreen Capital Management's iShares Biotechnology ETF position peaked at $8.45M in Q1 2023.
- 995 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.
Based on Evergreen Capital Management's 13F filing for Q3 2026, filed 23 Oct 2026.